Microsoft Corporation (MSFT) — closed signal from August 30, 2025
Partial Published before the outcome was known, scored automatically when the window closed on November 28, 2025.
Predicted vs. what happened
What happened
Reached 42% of the predicted growth at its peak, without hitting the target.
The thesis — published August 30, 2025
Microsoft could be due for a short-term recovery. The stock looks beaten down, yet excitement stays high because of its lead in AI, Azure cloud, and Copilot tools. A famous investor recently bought more shares, which can draw extra attention. The price is on the expensive side, but steady demand from cloud and AI makes the next few months clearer. With buying interest softer lately, the aim is a 3 month move back toward typical levels.
Primary drivers
- Strong AI lead and fast-growing Azure keep businesses spending
- Shares look washed out, which often leads to a short-term rebound
- Billionaire buying builds confidence and attracts more interest
- Slightly positive market helps prices drift back toward normal
How it played out
MSFT: the thesis stayed below target
Lyra published MSFT at $505.74 on 2025-08-30 with expected growth of 22%. The thesis pointed to a short-term recovery from a beaten-down stock, continued business spending tied to artificial intelligence, Azure cloud, and Copilot tools, more attention from a famous investor buying shares, and a slightly positive market.
Inside the window, MSFT rose to a peak of $552.69 on 2025-10-28, a 9.3% gain. It never reached the $615.85 target. By 2025-11-28, it ended at $492.01. The thesis partially played out because the stock did rebound, but the move stayed well below the target and finished under the publication price.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.